Form 4: Rallybio CFO Reports Routine Stock Transactions

Rallybio's Chief Financial Officer, Jonathan I Lieber, reported recent acquisitions and sales of company common stock, primarily for tax obligations.

Summary

• Jonathan I Lieber, Chief Financial Officer of Rallybio Corp (RLYB), reported transactions involving the company's common stock.
• On February 18, 2026, Mr. Lieber acquired 2,500 shares of common stock at a price of $0 per share.
• Following this acquisition, Mr. Lieber beneficially owned 4,904 shares directly.
• On February 23, 2026, Mr. Lieber disposed of 789 shares of common stock at a price of $5.06 per share.
• The sale of these 789 shares was solely to satisfy tax withholding obligations incurred upon the partial vesting of a performance stock award.
• After the reported transactions, Mr. Lieber directly beneficially owns 4,115 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The acquisition of shares is positive, but the subsequent sale for tax purposes is a routine administrative action that does not reflect a change in management's outlook on the company's prospects.

Positives

• The acquisition of 2,500 shares of common stock, likely through a grant or vesting, increases the CFO's direct stake in the company before the tax-related sale.

Negatives

• The disposition of 789 shares, even for tax purposes, reduces the direct beneficial ownership of the Chief Financial Officer.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to tax withholding upon vesting of equity awards, are common occurrences in publicly traded companies and are generally viewed as routine administrative events rather than indicators of significant strategic shifts or financial health.

Stakeholder Impact

• Shareholders: The impact on shareholders is minimal as this is a routine insider transaction, with a portion of shares sold to cover tax liabilities, which is a common practice for executive compensation.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions, specifically an acquisition of shares likely from a grant and a subsequent sale to cover tax obligations. Such transactions are common and do not typically provide sufficient new information to warrant a change in investment recommendation. A seasoned investor would consider this a non-material event for fundamental analysis.

Keywords

Rallybio, RLYB, Form 4, Insider Transaction, Chief Financial Officer, Common Stock, Stock Award, Tax Withholding